Eduardo Nagore
Overview
Explore the profile of Eduardo Nagore including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
196
Citations
4070
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Conway K, Edmiston S, Vondras A, Reiner A, Corcoran D, Shen R, et al.
JCO Precis Oncol
. 2024 Nov;
8:e2400375.
PMID: 39509669
Purpose: Patients with stage II and III cutaneous primary melanoma vary considerably in their risk of melanoma-related death. We explore the ability of methylation profiling to distinguish primary melanoma methylation...
2.
Association of MC1R variants with melanoma risk and interaction with sun exposure: An M-SKIP project
Stefanaki I, DEcclesiis O, Vignati S, Gaeta A, Kypreou K, Caini S, et al.
J Eur Acad Dermatol Venereol
. 2024 Oct;
PMID: 39425518
No abstract available.
3.
Rios-Vinuela E, Mayo-Martinez F, Nagore E, Millan-Esteban D, Requena C, Sanmartin O, et al.
Cancers (Basel)
. 2024 Jan;
16(2).
PMID: 38254900
Combined Merkel cell carcinoma (MCC) and squamous cell carcinoma (SCC) have classically been regarded as more aggressive than conventional, pure, Merkel cell polyomavirus (MCPyV)-positive MCC. It is still unknown whether...
4.
Manrique-Silva E, David M, Maider A, Garcia-Casado Z, Moro R, Requena C, et al.
Pigment Cell Melanoma Res
. 2023 Dec;
37(3):343-351.
PMID: 38153178
Differences in survival according to the pTERT mutation subtypes (-124C > T, -146C > T, and tandem -138_139CC > TT) have been observed. The present study aimed to describe the...
5.
Mayo-Martinez F, Moro R, Millan-Esteban D, Rios-Vinuela E, Bautista I, Nagore E, et al.
Cancers (Basel)
. 2023 Dec;
15(23).
PMID: 38067369
Extramammary Paget's disease (EMPD) is subclinical in extent and multifocal in nature. There is no global consensus for treatment, so its management represents a challenge in clinical practice. Therefore, we...
6.
Millan-Esteban D, Garcia-Casado Z, Macia A, de la Rosa I, Torrecilla-Vall-Llossera C, Penin R, et al.
Dermatology
. 2023 Nov;
240(1):164-169.
PMID: 37918362
Background: Subungual melanoma (SM) is an unusual type of melanocytic tumor affecting the nail apparatus. The mutational prevalence of the most prominently mutated genes in melanoma has been reported in...
7.
Peris K, Fargnoli M, Kaufmann R, Arenberger P, Bastholt L, Basset Seguin N, et al.
Eur J Cancer
. 2023 Aug;
192:113254.
PMID: 37604067
Basal cell carcinoma (BCC) is the most common malignant tumour in white populations. Multidisciplinary experts from European Association of Dermato-Oncology (EADO), European Dermatology Forum, European Society for Radiotherapy and Oncology...
8.
Chousakos E, Zugna D, Dika E, Boada A, Podlipnik S, Carrera C, et al.
Cancers (Basel)
. 2023 Aug;
15(15).
PMID: 37568805
A great portion of cutaneous melanoma's diagnoses nowadays is attributed to thin tumors with up to 1 mm in Breslow thickness (hereafter thin CMs), which occasionally metastasize. The objective of...
9.
Longo C, Navarrete-Dechent C, Tschandl P, Apalla Z, Argenziano G, Braun R, et al.
Dermatol Pract Concept
. 2023 Jul;
13(3).
PMID: 37403983
Introduction: Melanoma of the lentigo maligna (LM) type is challenging. There is lack of consensus on the optimal diagnosis, treatment, and follow-up. Objectives: To obtain general consensus on the diagnosis,...
10.
Gomez-Olivas J, Campos-Rodriguez F, Nagore E, Martorell A, Garcia-Rio F, Cubillos C, et al.
Chest
. 2023 Jun;
164(6):1551-1559.
PMID: 37348828
Background: OSA has been associated with increased incidence and aggressiveness of melanoma. However, the long-term impact of OSA and CPAP treatment on the prognosis of melanoma remains unexplored. Research Question:...